U.S. Software Stock News

If you are wondering whether Ameris Bancorp’s current share price lines up with its underlying worth, this breakdown is designed to help you size up the stock’s value with confidence. The shares recently closed at US$81.30, with returns of a 1.8% decline over 7 days, 8.1% over 30 days, 9.9% year to date, 25.5% over 1 year, 69.8% over 3 years and 97.6% over 5 years, which naturally raises questions about how much value is already reflected in the price. Recent coverage around Ameris Bancorp...

Marsh & McLennan Companies (MRSH) has wrapped up FY 2025 with fourth quarter revenue of US$6.6b and basic EPS of US$1.69, alongside net income of US$821m, while the trailing twelve months show revenue of US$27.0b and EPS of US$8.47 anchoring the full year picture. The company has seen quarterly revenue move from US$6.1b in Q4 2024 to US$6.6b in Q4 2025, with basic EPS in those periods at US$1.60 and US$1.69 respectively, presenting a set of results where solid top line scale is paired with...

Texas Capital Bancshares (TCBI) is back in focus after a strong fourth quarter and full year 2025, where earnings and revenue topped market expectations and management issued upbeat 2026 guidance. See our latest analysis for Texas Capital Bancshares. That upbeat earnings report, new 2026 guidance and a refreshed buyback plan have arrived alongside a 30 day share price return of 9.91% and a 90 day share price return of 20.50%, while the 1 year total shareholder return of 27.40% points to...

If you are wondering whether Aon shares at around US$342.95 still make sense for your portfolio, the key question is how that price lines up with the underlying value of the business. The stock has had mixed returns, with a 2.1% gain over the past week but a 3.8% decline over the last month and a 7.1% decline over the past year, which can change how investors view its growth potential and risk profile. Recent news coverage has largely focused on Aon's position as a major global insurance...

Multiple securities fraud class action lawsuits have been filed against Klarna Group (NYSE:KLAR). The suits allege material misstatements in Klarna’s IPO documents regarding risks tied to buy now, pay later loss reserves. Claims focus on disclosures around underwriting practices and credit loss reserves at the time of the IPO. Klarna Group, trading on the NYSE under the ticker NYSE:KLAR, last closed at $24.14. The stock has seen a 16.2% decline over the past week and a 16.9% decline over...

Berkshire Hathaway (BRK.A) is in the spotlight after longtime CEO Warren Buffett stepped down, and successor Greg Abel moved toward exiting the conglomerate’s large Kraft Heinz position, signaling a possible new approach to capital deployment. See our latest analysis for Berkshire Hathaway. Abel’s early portfolio reshaping comes as Berkshire’s share price sits around US$714,000 after a 1 day share price return of 0.63% and a year to date share price return of a 4.05% decline, while the 5 year...

In recent commentary, Tennant reported that sales have effectively flatlined over the past two years, while earnings per share have fallen each year. This combination of stagnating revenue and shrinking profitability suggests Tennant may need to rethink how it drives both demand and margins. Next, we will examine how Tennant’s stagnating sales backdrop shapes the company’s broader investment narrative and potential growth story. Uncover the next big thing with financially sound penny...

Amkor Technology (AMKR) has been in focus after its latest quarterly report, where both revenue and earnings surpassed analyst estimates and prompted investors to reassess what the recent share price strength might be pricing in. See our latest analysis for Amkor Technology. Those results come after a strong run for the shares, with a 30 day share price return of 23.76% and a 90 day gain of 54.89%. The 1 year total shareholder return of 103.91% highlights how much sentiment around Amkor...

Axos Financial (AX) has drawn fresh attention after recent trading, with the stock last closing at $94.64. For investors, the current discussion centers on how its banking and securities mix aligns with recent returns. See our latest analysis for Axos Financial. Recent moves have been mixed, with a 1 day share price return of 3.03% and a 30 day share price return of 9.08%, while the 1 year total shareholder return of 35.92% and 5 year total shareholder return of 119.48% point to momentum that...

CVB Financial (CVBF) just wrapped up a busy quarter, with fourth quarter and full year 2025 results topping Wall Street’s revenue and earnings expectations, alongside the completion of a previously announced share repurchase program. See our latest analysis for CVB Financial. Despite the latest quarter beating expectations and the completion of a US$80.4 million buyback covering 3.12% of shares, recent trading has been mixed, with a 6.21% 90 day share price return and a 1 year total...

Cimpress (CMPR) has put up a busy Q2 2026, with revenue at US$1.0 billion and basic EPS of US$2.01, alongside net income of US$49.3 million. The trailing twelve months show revenue of US$3.6 billion and EPS of US$0.95 tied to net income of US$23.4 million. The company has seen quarterly revenue move from US$939.2 million in Q2 2025 to US$1.0 billion in Q2 2026, while basic EPS has shifted from US$2.45 to US$2.01 over the same period. This sets up a picture where top line scale is being tested...

Liquidia (LQDA) recently announced it will share interim and open label clinical data for LIQ861, branded as YUTREPIA, and investigational L606 at the PVRI 2026 Annual Congress, giving investors fresh detail on its pulmonary hypertension pipeline. See our latest analysis for Liquidia. The PVRI 2026 data update comes after a strong run in Liquidia’s share price, with a 30 day share price return of 25.07% and a 90 day share price return of 76.77%, while the 1 year total shareholder return is...

Abbott Laboratories (NYSE:ABT) announced a pending US$21b acquisition of Exact Sciences. The deal marks a major move into cancer diagnostics for Abbott. The acquisition comes as Abbott reports underperformance in its nutrition segment and weaker sales growth. Management has publicly acknowledged operational pressures, including increasing production costs. Abbott Laboratories, best known for its diversified healthcare portfolio across diagnostics, medical devices, nutrition and established...

BioNTech has started a Phase III clinical trial for its oncology candidate BNT324 in metastatic castration-resistant prostate cancer. The company is moving further into oncology therapeutics beyond its vaccine portfolio. BioNTech appointed Kylie Jimenez as Chief People Officer to support its shift toward a multi-product oncology business. BioNTech, listed as NasdaqGS:BNTX, is trading at $116.77, with the share price up 22.6% over the past 30 days and 20.8% year to date. Returns over 1 year...

The Hartford Insurance Group reported past full-year 2025 results showing revenue of US$28.37 billion and net income of US$3.84 billion, both higher than the prior year. This earnings strength comes against a backdrop of generally steady analyst expectations before the release, highlighting how Hartford’s reported performance outpaced earlier cautious sentiment. Against this backdrop of stronger full-year earnings, we’ll now examine how Hartford’s higher revenue and profit shape its broader...

General Motors (NYSE:GM) recorded a $7.6b write down on its electric vehicle business and is restructuring its EV assets. The company is scaling back EV production plans and divesting certain EV assets in response to weaker demand and shifting policy conditions. GM is working with Ford and others to support a financial rescue for key supplier First Brands Group, which is in bankruptcy. The automaker is emphasizing higher margin software and subscription revenue, while increasing its dividend...

Halozyme Therapeutics (HALO) put fresh numbers on the table with updated 2025 revenue guidance of US$1.385b to US$1.40b and higher 2026 targets, tied to ENHANZE, new deals and recent acquisitions. See our latest analysis for Halozyme Therapeutics. The upbeat guidance and recent deals appear to be feeding into sentiment, with the share price at US$73.34 and a 30 day share price return of 8.33%, while the 1 year total shareholder return of 29.99% suggests momentum has been building over a...

In late January 2026, Anthropic introduced its “Cowork” AI task-management tool, intensifying competitive pressure on Atlassian’s core project and work-management products and prompting fresh scrutiny of its long-term positioning. This development highlights how rapidly AI-native entrants can challenge established software platforms, raising important questions about Atlassian’s product differentiation and customer stickiness as workflows become more automated. We’ll now examine how concerns...

With no single headline event driving Polaris (PII) today, investors are instead focusing on the stock’s recent returns and fundamentals, including revenue of US$7,236.3m and a reported net loss of US$465.5m. See our latest analysis for Polaris. Polaris shares trade at US$64.68 after a recent 7 day share price decline of 8.8%, while the 1 year total shareholder return of 39.3% contrasts with weaker 3 and 5 year total shareholder returns that point to fading longer term momentum. If Polaris...

Intercontinental Exchange (NYSE:ICE) has launched Reddit Signals and Sentiment, an AI powered data suite that turns Reddit discussions into market intelligence for investors. The product is designed to translate crowdsourced conversations into near real time sentiment indicators that can be used alongside traditional financial data. The launch highlights ICE’s push to expand its data and analytics offerings beyond its core exchange and clearing services. Intercontinental Exchange operates...

Fluence Energy (NasdaqGS:FLNC) disclosed a year over year increase in CEO Julian Nebreda's total compensation in its latest filing. The filing also highlighted significant changes in positions held by major institutional investors in the company. These updates relate directly to how leadership is rewarded and how large shareholders are adjusting their exposure to Fluence Energy. Fluence Energy focuses on grid scale energy storage and related services, an area that connects directly to...

BigBear.ai Holdings (BBAI) just announced a new partnership with Maqta Technologies, the digital arm of AD Ports Group, to co-develop AI tools for customs and border operations at ports and critical cargo hubs. See our latest analysis for BigBear.ai Holdings. Against the backdrop of this new Maqta partnership and a recent proposal to increase authorized shares, BigBear.ai’s 1-year total shareholder return of 33.98% contrasts with a 90-day share price return decline of 20.23%, suggesting...

Deere & Company (NYSE:DE) is expanding its U.S. footprint with two new facilities, a distribution center in Indiana and an excavator factory in North Carolina. The expansion includes significant investment in manufacturing capacity and supply chain efficiency, alongside commitments to add hundreds of jobs. The announcement underscores Deere's focus on U.S. production, logistics, and long term support for its equipment customers. For investors tracking Deere at a share price of $530.07, this...

Bitmine Immersion Technologies (NYSEAM:BMNR) confirmed the board-approved departure of President Erik Nelson following an agreement between the parties. The leadership change comes as the company accelerates Ethereum accumulation and launches large scale staking operations. Bitmine also committed a $200 million investment to Beast Industries during this period of significant capital deployment. Bitmine Immersion Technologies operates in the digital asset infrastructure space, with a focus...